PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,660 | -27.5% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2024 | $2,290 | +15.7% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q4 2023 | $1,980 | +52.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,300 | -19.8% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,620 | -23.9% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $2,130 | -42.4% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,700 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,922,570 | $19,053,000 | 7.16% |
| DAFNA Capital Management LLC | 1,114,000 | $11,040,000 | 3.79% |
| RTW INVESTMENTS, LP | 4,779,135 | $47,361,000 | 1.79% |
| Kerrisdale Advisers, LLC | 448,880 | $4,448,000 | 1.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 805,000 | $7,978,000 | 0.66% |
| Artal Group S.A. | 1,300,000 | $12,883,000 | 0.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,571,319 | $45,302,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $2,194,000 | 0.09% |
| COWEN AND COMPANY, LLC | 103,727 | $1,028,000 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $595,000 | 0.07% |